In one paragraphArticle in Pharmaceuticals (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
9 authors.
Adiel Ortega-AyalaDepartment of Pharmacology, Faculty of Medicine, National Autonomous University of Mexico, Mexico City 04510, Mexico.ORCID 0000-0003-1300-5364 Carla González de la CruzPersonalised Medicine and Mental Health Unit, University Institute for Biosanitary Research of Extremadura (INUBE), 06080 Badajoz, Spain.ORCID 0009-0007-6787-7025 Lorena MoraLaboratorio Clínico, Dispensario Central del Instituto Ecuatoriano de Seguridad Social (IESS), Quito 170901, Ecuador.
Mauro BonillaColegio de Ciencias de la Salud, Universidad San Francisco de Quito (USFQ), Quito 170901, Ecuador.
Leandro TanaColegio de Ciencias de la Salud, Universidad San Francisco de Quito (USFQ), Quito 170901, Ecuador.ORCID 0000-0003-2332-641X Fernanda Rodrigues-SoaresPersonalised Medicine and Mental Health Unit, University Institute for Biosanitary Research of Extremadura (INUBE), 06080 Badajoz, Spain.ORCID 0000-0002-2559-3223 Pedro DoradoPersonalised Medicine and Mental Health Unit, University Institute for Biosanitary Research of Extremadura (INUBE), 06080 Badajoz, Spain.ORCID 0000-0003-4100-721X Adrián LLerenaPersonalised Medicine and Mental Health Unit, University Institute for Biosanitary Research of Extremadura (INUBE), 06080 Badajoz, Spain.ORCID 0000-0002-5663-7081 Enrique TeránRIBEF Red Iberoamericana de Farmacogenégica y Farmacogenómica SIFF, 06080 Badajoz, Spain.ORCID 0000-0001-6979-5655 Funding
Agencia Extremeña de Cooperación Internacional para el desarrollo (AEXCID) 24IA001Conselho Nacional de Desenvolvimento Científico e Tecnológico, Brazil 200824/2021-4Universidad de San Francisco de Quito HUBI 5459
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
antidiabetic drugsCYP2C19CYP2C8CYP2C9molecular ancestrySLC22 familyT2DM
Identifiers
PMID41011206
PMCPMC12472588
What Socratic holds
Textmetadata
LicenceCC BY
Read underepoch 390